Dyslipidemia Competency (2025)

Request edit access

JavaScript isn't enabled in your browser, so this file can't be opened. Enable and reload.

This quiz will assess your baseline knowledge during your ambulatory care rotation. This will not be included your final rotation grade but will serve to identify areas for improvement. Therefore, please do not utilize any outside references to complete this quiz.

Email *

Record my email address with my response

According to the 2018 ACC/AHA Cholesterol Guidelines, which of the following would be considered strong candidates for statin therapy? (select all that apply) *

1 point

87 year-old female with Alzheimer's disease, hypothyroidism, who has a LDL 93 mg/dL and 10-year ASCVD risk score of 15%.

62 year-old male with osteoarthritis, hypertension, and ischemic stroke, who has a LDL 110 mg/dL and a ASCVD score of 7.5%

42 year-old female with diabetes, endometriosis, obesity, who has a LDL 78 mg/dL and has a 10-year ASCVD risk score of 5%

48 year-old female with hypertension, breast cancer, and poly cystic ovarian syndrome, who has a LDL 92 mg/dL and has a 10-year risk score of 6%

A 51 year-old male with tobacco use disorder and depression, who has a LDL 201 mg/dL and a ASCVD risk score of 4%

Required

Which of the following agent(s) is/are used PRIMARILY for lowering triglycerides? Select all that apply. *

1 point

Fenofibrate

Pravastatin

Evolocumab

Lovaza

Cholestyramine

Required

Which of the following statins are considered moderate-intensity? Select all that apply. *

1 point

Pitavastatin 5mg

Atorvastatin 20mg

Rosuvastatin 40mg

Pravastatin 80 mg

Atorvastatin 10mg

Required

Which of the following statement(s) regarding side effects is/are TRUE? Select all that apply. *

1 point

Patients who experience myalgia with a statin should never be rechallenged

Omega-3 fatty acids may cause dyspepsia and burping

Diphenhydramine may be given before niacin administration to address possible flushing

Fish oil may increase risk of bleeding

Ezetimibe is a poorly tolerated medication and should be taken with food

Required

GH is a 52 year old black male with a PMH NSTEMI, T2DM, HTN, and BPH. He quit smoking 4 years ago and was previously smoking 1 pack per day. His most recent BP was 130/92. Medications include lisinopril 40mg daily, metformin XR 2000mg daily, tamsulosin 0.4mg daily, finasteride 5mg daily, acetaminophen 500mg every 6 hours as needed. His lipid panel is as follows: TC 139 mg/dL, HDL 38 mg/dL, LDL 50 mg/dL. Based on the following information and according to the 2025 AACE Cholesterol Guidelines, what is GH's LDL goal? *

1 point

<130

<100

<70

<55

YD is a 50 year-old Hispanic male with a PMH schizoaffective disorder, polysubstance use disorder, hypertension, and newly diagnosed diabetes who is seeing you for chronic disease management. He is currently taking aripiprazole 15mg daily, ranitidine 150mg twice daily, amlodipine 10mg daily, metformin 500mg twice daily, and ibuprofen 600mg every 6 hours as needed. He currently smokes 1 PPD and drinks one beer 1-2 times per week. His most recent VS are as follows: HR 73 BP 140/78. His lipid panel is as follows: TC 241 mg/dL, HDL 38 mg/dL TG 193 mg/dL. ASCVD 10-yr risk score is 31%. What is his LDL-C? *

1 point

164 mg/dL

101 mg/dL

98 mg/dL

195 mg/dL

122 mg/dL

Based on the information you have for YD, what would you recommend for lipid treatment using the 2018 ACC/AHA Cholesterol Guidelines? *

1 point

Simvastatin 40mg daily

Rosuvastatin 20mg daily

Atorvastatin 10mg daily

Lovastatin 40mg daily

Rosuvastatin 10mg daily

JJ is a 44 year old woman with a baseline LDL of 192. She is started on atorvastatin 40mg daily. When should her lipids be rechecked? *

1 point

2-4 weeks

4-12 weeks

12-24 weeks

Annually

AH is a 48 year old female with PMH of DM, HTN, CKD (CrCl 28mL/min), and HLD. She currently takes simvastatin 20mg daily, amlodipine 10mg daily, and metformin 500mg twice daily. She reports (+) adherence and most recent FLP results as follows: TC 225, TG 138, HDL 50, LDL 147. Baseline LDL was 188 1 year ago. Which of the following would be reasonable next steps for AH to help lower her cholesterol? *

1 point

Increase simvastatin to 40mg daily

Transition simvastatin to atorvastatin 10mg daily

Transition simvastatin to rosuvastatin 10mg daily

Add ezetimibe 10mg daily

BZ is a 38 year old male with a PMH of NSTEMI, HTN, and HeFH. According to the 2018 ACC/AHA Cholesterol Guidelines, what risk level would BZ’s ASCVD be considered? *

1 point

Moderate risk

High risk

Very high risk

Extreme risk

BZ agrees to start statin therapy with rosuvastatin 40mg daily + therapeutic life changes with jogging 30 min 1x/week. and is now back in the clinic three months later for follow up. He reports (+) adherence to both meds/TLC and FLP results are as follows: TC 191, TG 146, HDL 61, LDL 100 (baseline 191). He is concerned about his current cardiac risk and asks about next steps. According to the 2022 ACC Expert Consensus Decision Pathway on non-statin therapies, which of the following would be reasonable to first recommend to BZ? (select all that apply) *

1 point

Increase rosuvastatin to 80mg daily

Add bempedoic acid

Add ezetimibe

Add PSCK-9 inhibitor

Add inclisirin

Required

Submit

Clear form

This form was created inside of Cambridge Health Alliance.

Does this form look suspicious? Report

Forms